Low-Dose Methotrexate May Increase Risk of Melanoma
Exposure to low-dose methotrexate is associated with an increased risk of melanoma, according to a meta-analysis of 17 studies.
Melanoma
No Survival Benefit With T-VEC in Advanced Melanoma
Adding T-VEC to pembrolizumab does not improve survival in patients with advanced melanoma, a phase 3 study suggests.
Data Reveal Growing Burden of Metastatic Cancers in the US
The prevalence of metastatic cancers in the US has risen in recent years and will increase further by 2025, according to researchers.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Incidence of Melanoma Diagnosis, Biopsy Parallel Skin Screening Uptake
Researchers sought to determine if the incidence of melanoma diagnoses and biopsies increased with a greater uptake of skin screenings.
Skin Cancer Awareness Month: Protection Is Prevention
Patient awareness of sun damage doesn’t always translate into safer sun practices, finds Lisa Nyanda-Manola, MD. She describes how she counsels her patients, especially those with skin of color, to protect themselves.
Pembrolizumab a Successful Adjuvant Treatment for High-Risk Melanoma
Recurrence-free survival in patients with melanoma treated with pembrolizumab are reported.
US Melanoma Incidence May Be Stabilizing for First Time in a Century
Data suggest the overall incidence of melanoma in the United States is stabilizing after nearly a century of continuous increase.
Opdualag Approved for Unresectable, Metastatic Melanoma
Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody.
Sunburn Diagnosis More Prevalent in Obese Individuals
The relationship between obesity and sunburn diagnosed during a medical examination is examined.
- Loading...
Loading...
Next post in Dermatology
Loading... 
Loading...